International Biotechnology Trust (IBT) offers a highlydifferentiated source of equity income, and targets a yield of 4% drawn from the capital growth generated by a diversified portfolio of biotechnology companies, the majority of which are based in the United States. The trust has a very strong track record and as at the end of February 2018 had generated annualised NAV total returns of 17.35% under the stewardship of fund manager Carl Harald Janson, who took the reins in September 2013 and ru ....
04 Apr 2018
International Biotechnology Trust - Overview
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
International Biotechnology Trust - Overview
International Biotechnology Trust PLC (IBT:LON) | 627 0 0.0% | Mkt Cap: 236.9m
- Published:
04 Apr 2018 -
Author:
Kepler Partners Research Team -
Pages:
6
International Biotechnology Trust (IBT) offers a highlydifferentiated source of equity income, and targets a yield of 4% drawn from the capital growth generated by a diversified portfolio of biotechnology companies, the majority of which are based in the United States. The trust has a very strong track record and as at the end of February 2018 had generated annualised NAV total returns of 17.35% under the stewardship of fund manager Carl Harald Janson, who took the reins in September 2013 and ru ....